Scarica l'app Stockscreener
8.5725
10.01%
0.7803
Dopo l'orario di chiusura:
8.57
-0.0025
-0.03%
Precedente Chiudi:
$7.7922
Aprire:
$8.5725
Volume 24 ore:
842
Relative Volume:
0.08
Capitalizzazione di mercato:
$8.72M
Reddito:
$630.00K
Utile/perdita netta:
$5.72M
Rapporto P/E:
-25.10
EPS:
-0.3415
Flusso di cassa netto:
$-6.75M
1 W Prestazione:
+12.80%
1M Prestazione:
+20.74%
6M Prestazione:
-19.88%
1 anno Prestazione:
+5.70%
Intervallo 1D:
$8.5725
$8.5725
Intervallo di 1 settimana:
$7.6901
$8.59
Portata 52W:
$6.51
$13.27
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Nome
Addex Therapeutics Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ADXN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
8.5725 | 8.72M | 630.00K | 5.72M | -6.75M | -0.3415 |
|
VRTX
Vertex Pharmaceuticals Inc
|
498.86 | 126.60B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
590.00 | 64.75B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
639.90 | 36.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.13 | 31.40B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
102.43 | 28.98B | 2.98B | -717.57M | -264.74M | -2.9987 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-31 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr Borsa (ADXN) Ultime notizie
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges - TipRanks
Addex Therapeutics Reports Strong 2024 Financial Turnaround - TipRanks
META_TITLE_SECTORS - Yahoo Finance
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149 - GlobeNewswire Inc.
Coincheck Group N.V (CNCK) produces promising results - US Post News
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Addex Stock Soars on Crucial Update From Indivior Research Deal - MSN
Golden Heaven Group secures investment of $25.2M - MSN
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Yahoo Finance
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock - MSN
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Drug discovery and bringing new medicine to marketthe future of AI in pharma - OutSourcing-Pharma.com
What Makes Addex Therapeutics (ADXN) a New Buy Stock - Nasdaq
Earnings call: Addex Therapeutics reports half-year financials and R&D updates - Investing.com
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder - Yahoo Finance
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
LYRA Stock Quote Price and Forecast - CNN
Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket - Benzinga
Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Addex Therapeutics (ADXN) Stock Rallied 62.1% on Phase 2 Study - AskTraders.com
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13% - Investing.com
ADXN Stock Price and Chart — SIX:ADXN - TradingView
Addex Therapeutics Ltd Adr Azioni (ADXN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.89%
1.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):